Development of stabilized itraconazole nanodispersions by using high-gravity technique

References

• Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A et al. (2001). Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy. Antimicrob Agents Chemother, 45:981–985.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO 3rd. (2008). Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm, 5:968–980.
   PubMed Web of Science ®Google Scholar
• Barrett AM, Dehghani F, Foster NR. (2008). Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier. Pharm Res, 25:1274–1289.
   PubMed Web of Science ®Google Scholar
• Sun W, Mao S, Shi Y, Li LC, Fang L. (2011). Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci, 100:3365–3373.
   PubMed Web of Science ®Google Scholar
• Yang W, Johnston KP, Williams RO 3rd. (2010). Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm, 75:33–41.
   PubMed Web of Science ®Google Scholar
• Kim JK, Park JS, Kim CK. (2010). Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm, 383:209–215.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Vercruysse S, Martens JA, Vermant J, Froyen L, Van Humbeeck J et al. (2008). Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions – a case study with itraconazole. Eur J Pharm Biopharm, 70:590–596.
   PubMed Web of Science ®Google Scholar
• Lee S, Nam K, Kim MS, Jun SW, Park JS, Woo JS et al. (2005). Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. Arch Pharm Res, 28:866–874.
   PubMed Web of Science ®Google Scholar
• Chingunpitak J, Puttipipatkhachorn S, Tozuka Y, Moribe K, Yamamoto K. (2008). Micronization of dihydroartemisinin by rapid expansion of supercritical solutions. Drug Dev Ind Pharm, 34:609–617.
   PubMed Web of Science ®Google Scholar
• Shanmugam S, Park JH, Chi SC, Yong CS, Choi HG, Woo JS. (2011). Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process. Drug Dev Ind Pharm, 37:628–637.
   PubMed Web of Science ®Google Scholar
• Vaughn JM, Gao X, Yacaman MJ, Johnston KP, Williams RO 3rd. (2005). Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques. Eur J Pharm Biopharm, 60:81–89.
   PubMed Web of Science ®Google Scholar
• Vaughn JM, McConville JT, Crisp MT, Johnston KP, Williams RO 3rd. (2006). Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev Ind Pharm, 32:559–567.
   PubMed Web of Science ®Google Scholar
• Rogers TL, Nelsen AC, Sarkari M, Young TJ, Johnston KP, Williams RO 3rd. (2003). Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying. Pharm Res, 20:485–493.
   PubMed Web of Science ®Google Scholar
• McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS et al. (2006). Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm Res, 23:901–911.
   PubMed Web of Science ®Google Scholar
• Vaughn JM, McConville JT, Burgess D, Peters JI, Johnston KP, Talbert RL et al. (2006). Single dose and multiple dose studies of itraconazole nanoparticles. Eur J Pharm Biopharm, 63:95–102.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO 3rd, Johnston KP. (2007). Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm, 4:782–793.
   PubMed Web of Science ®Google Scholar
• Kumar V, Wang L, Riebe M, Tung HH, Prud’homme RK. (2009). Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. Mol Pharm, 6:1118–1124.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Hotze MA, Johnston KP, Williams RO 3rd. (2006). Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir, 22:8951–8959.
   PubMed Web of Science ®Google Scholar
• Rasenack N, Hartenhauer H, Müller BW. (2003). Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm, 254:137–145.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO 3rd, McGinity JW. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm, 36:1064–1078.
   PubMed Web of Science ®Google Scholar
• Dontireddy R, Crean AM. (2011). A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Dev Ind Pharm, 37:1141–1149.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang D, Butler R, Campbell NL, Long J, Tan B et al. (2008). Formation and enhanced biocidal activity of water-dispersable organic nanoparticles. Nat Nanotechnol, 3:506–511.
   PubMed Web of Science ®Google Scholar
• Zhong J, Shen Z, Yang Y, Chen J. (2005). Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment. Int J Pharm, 301:286–293.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Y, Guo F, Wang X, Zheng C. (2000). Synthesis of nanoparticles with novel technology: high-gravity reactive precipitation. Ind Eng Chem Res, 39:948–954.
   Web of Science ®Google Scholar
• Chen JF, Li YL, Wang YH, Yun J, Cao DP. (2004). Preparation and characterization of zinc sulfide nanoparticles under high-gravity environment. Mater Res Bull, 39:185–194.
   Web of Science ®Google Scholar
• Chen JF, Zhou MY, Shao L, Wang YY, Yun J, Chew NY et al. (2004). Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int J Pharm, 269:267–274.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang J, Shen Z, Zhong J, Yun J. (2006). Preparation and characterization of amorphous cefuroxime axetil drug nanoparticles with novel technology: high-gravity antisolvent precipitation. Ind Eng Chem Res, 45:8723–8727.
   Web of Science ®Google Scholar
• Sanganwar GP, Gupta RB. (2008). Enhancement of shelf life and handling properties of drug nanoparticles: nanoscale mixing of itraconazole with silica. Ind Eng Chem Res, 47:4717–4725.
   Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm, 212:213–221.
   PubMed Web of Science ®Google Scholar
• Chaubal MV, Popescu C. (2008). Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res, 25:2302–2308.
   PubMed Web of Science ®Google Scholar
• Amidon G, Bergren M, Grant D, Marshall K, Itai S. (1999). Physical test methods for powder flow characterization of pharmaceutical materials: A review of methods. Pharmacopeial Forum, 35:8293–8308.
   Google Scholar
• Meyer K, Zimmermann I. (2004). Effect of glidants in binary powder mixtures. Powder Technol, 139:40–54.
   Web of Science ®Google Scholar
• Jonat S, Hasenzahl S, Drechsler M, Albers P, Wagner KG, Schmidt PC. (2004). Investigation of compacted hydrophilic and hydrophobic colloidal silicon dioxides as glidants for pharmaceutical excipients. Powder Technol, 141:31–43.
   Web of Science ®Google Scholar
• Zhao H, Wang J, Wang Q, Chen J, Yun J. (2007). Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Ind Eng Chem Res, 46:8229–8235.
   Web of Science ®Google Scholar
• Le Y, Ji H, Chen JF, Shen Z, Yun J, Pu M. (2009). Nanosized bicalutamide and its molecular structure in solvents. Int J Pharm, 370:175–180.
   PubMed Web of Science ®Google Scholar